Cardiovascular Risk Factors on the Rise in Asia, Particularly in Japan and China

In Japan and China, there is an increasing incidence of hypertension and is completely different than the US where rates of hypertension did not change.

Cardiovascular risk factors like high cholesterol, hypertension and diabetes is increasing in Asia, particularly Japan. Using data from earlier studies and examining a health program launched by the Japanese government, researchers found many risk factors in the Japanese population remain unchanged or even worsened over more than a decade.

In Japan and China, there is an increasing incidence of hypertension and is completely different than the US where rates of hypertension did not change. Many risk factors in the Japanese population remain unchanged or even worsened over more than a decade.

Cardiovascular Risks in Men With Low Testosterone Levels Not Increased by TRT
Taking supplemental testosterone does not increase risk of experiencing a major adverse cardiac event, such as a heart attack or stroke, in men who have undergone testosterone replacement therapy.

"Cardiovascular disease deaths in Japan have increased and the prevalence of risk factors is expected to increase as the Japanese population continues to age," said guest editor Masafumi Kitakaze in the Journal of the American College of Cardiology.

On the other hand, there has been an overall decline in coronary artery disease-related mortality in the US and Europe. This decline has been attributed to reductions in risk factors and the promotion of treatments.

"Data collection on patients, not only in Japan but in Asia and around the world, is key to understanding the status of cardiovascular disease and determining the future direction of care," Kitakaze said.

Having Four or More Children Increases Cardiovascular Risk in Women
A study led by an Indian-American woman in Texas has revealed that women with fewer kids than four have lesser risk of developing heart problems.

By combining data collection with clinical trials, the cardiovascular community can continue to develop new treatments and improve outcomes for patients.

"Focusing attention and research efforts on these parameters for varied cardiovascular disease will help us better understand how to improve treatment for our patients across the globe," said Valentin Fuster, editor-in-chief of the Journal of the American College of Cardiology.

Linkage Between Testosterone Therapy And Cardiovascular Risk are Misplaced
Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, shows a review published in this month's Mayo Clinic Proceedings.

Source-IANS

Type 2 Diabetes Drug Januvia Does Not Increase Cardiovascular Risk in Patients
Those who took Januvia, and had regular care for Type 2 Diabetes, did not show any significant heart problems, compared to those who didn't take the drug.